These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928 [TBL] [Abstract][Full Text] [Related]
16. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778 [TBL] [Abstract][Full Text] [Related]
17. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia. Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021 [TBL] [Abstract][Full Text] [Related]
18. Peripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigen. Bojarska-Junak A; Hus I; Szczepanek EW; Dmoszyńska A; Roliński J Leuk Res; 2008 Feb; 32(2):225-33. PubMed ID: 17675228 [TBL] [Abstract][Full Text] [Related]